AGIO - Agios Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.46B
Enterprise Value 32.17B
Trailing P/E N/A
Forward P/E 1-6.03
PEG Ratio (5 yr expected) 1-0.15
Price/Sales (ttm)24.18
Price/Book (mrq)4.61
Enterprise Value/Revenue 321.39
Enterprise Value/EBITDA 6-5.45

Trading Information

Stock Price History

Beta (3Y Monthly) 2.18
52-Week Change 3-42.00%
S&P500 52-Week Change 31.73%
52 Week High 385.00
52 Week Low 338.62
50-Day Moving Average 344.69
200-Day Moving Average 353.42

Share Statistics

Avg Vol (3 month) 3543.15k
Avg Vol (10 day) 3526.9k
Shares Outstanding 5N/A
Float 51.41M
% Held by Insiders 112.93%
% Held by Institutions 1102.15%
Shares Short (Jul 31, 2019) 49.51M
Short Ratio (Jul 31, 2019) 418.7
Short % of Float (Jul 31, 2019) 437.35%
Short % of Shares Outstanding (Jul 31, 2019) 416.19%
Shares Short (prior month Jun 28, 2019) 49.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-400.22%

Management Effectiveness

Return on Assets (ttm)-28.54%
Return on Equity (ttm)-57.44%

Income Statement

Revenue (ttm)101.66M
Revenue Per Share (ttm)1.74
Quarterly Revenue Growth (yoy)-35.10%
Gross Profit (ttm)-248.33M
EBITDA -399.11M
Net Income Avi to Common (ttm)-389.41M
Diluted EPS (ttm)-6.67
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)495.39M
Total Cash Per Share (mrq)8.43
Total Debt (mrq)116.47M
Total Debt/Equity (mrq)21.86
Current Ratio (mrq)5.96
Book Value Per Share (mrq)9.07

Cash Flow Statement

Operating Cash Flow (ttm)-329.45M
Levered Free Cash Flow (ttm)-178.21M